Clinical Trials Logo

Filter by:
NCT ID: NCT05706272 Active, not recruiting - Frailty Clinical Trials

Secure and Focused Primary Care for Older pEople

SAFE
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The population worldwide is aging. The demographic change is challenging to health care organizations and highlights the need for effective preventive and proactive care models in primary care, especially for older people. This study, "Secure and focused primary care for older people" (SAFE), investigates the effectiveness of a new proactive care model based on comprehensive geriatric assessment (CGA) in primary care in a population with high risk of hospitalisation.

NCT ID: NCT05696119 Active, not recruiting - Health Behavior Clinical Trials

Implementing Injury Prevention Training in Youth Handball (I-PROTECT) Using the RE-AIM Evaluation Framework

I-PROTECT
Start date: May 31, 2023
Phase: N/A
Study type: Interventional

The aim of this two-armed cluster-randomized controlled trial is to investigate the implementation of the I-PROTECT using the RE-AIM evaluation framework that addresses five dimensions of effectiveness and implementation of interventions: reach, effectiveness, adoption, implementation, and maintenance.

NCT ID: NCT05691803 Active, not recruiting - Physical Inactivity Clinical Trials

Understanding Motivation Towards Exercise to Enhance Physical Activity on Prescription Adherence - Feasibility Study

UMEPA-F
Start date: February 3, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to explore feasibility and evaluate methods to investigate changes in physical activity, function and psychometrics in relation to an exercise intervention in physically inactive middle-aged men and women. The main questions it aims to answer are: - Is the exercise intervention feasible regarding retention and user experience? - Is the evaluation methods on physical activity, function and psychometrics suitable for the present study? - Is there an intervention effect in physical activity, function and psychometrics at three and six month post baseline? - Can barriers and facilitators towards increased physical activity be identified in the two groups of the study? All participants will first receive standard care for physically inactive patients, i.e. Physical activity on Prescription (PaP), followed by allocation to an exercise intervention (EI) group. The EI group will be offered an additional exercise intervention for 12 weeks consisting of 1-2 training sessions per week of a combination of aerobic and resistance training at a private fitness center. Feasibility of the exercise intervention will be evaluated based on retention rates and user experience. Additionally, researchers will assess physical activity, function and psychometrics in the EI group at three and six months to evaluate the suitability of the chosen methods and to get preliminary data on the intervention effect. Finally, interviews with the participants in the control and EI groups will be performed at the end of the study in order to explore barriers and facilitators towards increased physical activity in formally inactive patients. Edit after registration of the study: Due to a lower number of recruited participants than expected (20 instead of the anticipated 30), the protocol was updated by removing the control group that would initially consist of 10 participants. The remaining 20 participants were all allocated to the exercise intervention group to assess feasibility of the intervention.

NCT ID: NCT05689684 Active, not recruiting - Diabetes Type 2 Clinical Trials

Arabinoxylan-oligosaccharides (AXOS) for the Management of Type-2 Diabetes

Start date: November 7, 2022
Phase: N/A
Study type: Interventional

The project aims to achieve significantly improved clinical care for type 2 diabetes. The current standard treatment metformin has low adherence due to its main side effect gut dysbiosis, which also results in more complications and high overall costs. Prebiotics have been suggested as a medical food and might be helpful as adjuvant management in type 2 diabetes and other metabolic diseases. Carbiotix AB has developed, a corn fiber extract containing arabinoxylan-oligosaccharides (AXOS), which have great potential for improving gut health. In this project, it will be investigated whether the intake of a hybrid product containing AXOS together with metformin can significantly improve glucose metabolism and gut health in patients with type 2 diabetes.

NCT ID: NCT05686512 Active, not recruiting - Anxiety Disorder Clinical Trials

Initial Evaluation of a Stepped Care Model for Treating Mild to Moderate Childhood Anxiety in Primary Care

Start date: February 13, 2023
Phase: N/A
Study type: Interventional

Objectives: In the past ten years in Sweden, a new form of primary care units called first line mental health (FLMH) has been implemented to improve mental health services for children and adolescents. Using a structured and collaborative approach including experts, clinicians, and patients, the investigators have developed a transdiagnostic psychological intervention for anxiety based on cognitive behavioural therapy (CBT) that aims to fit the FLMH care context. The current study aims to test the CBT intervention "Step-by-Step" in a randomized pilot study (N=36) to explore the feasibility of the study design. Rationale for study: Childhood anxiety is common and associated with suffering and impairment in several life areas. CBT is an evidence-based treatment for anxiety disorders in children, but there is a need of increasing access to treatment. Offering CBT for childhood anxiety in primary care is a way to offer early and accessible treatment. However, there is a lack of CBT interventions developed for and evaluated in primary care. Prior to a properly powered randomized controlled study, evaluating efficacy of the Step-by-Step, the investigators need to conduct a pilot study to, primarily, establish the feasibility of the study design and trial procedures and secondarily, provide preliminary data on acceptability and clinical efficacy.

NCT ID: NCT05678647 Active, not recruiting - Blood Donation Clinical Trials

Sucrosomial Iron and Iron Sulphate to Blood Donors

Start date: January 31, 2023
Phase: N/A
Study type: Interventional

2 different oral iron supplementations after blood donation are compared.

NCT ID: NCT05678101 Active, not recruiting - Hip Fractures Clinical Trials

TENS for Relief of Postoperative Pain in Orthopedic Patients

Start date: November 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

To ensure early mobilization, minimize suffering, and to prevent postoperative complications postoperative pain, should be reduced as soon and as effectively as possible. A non-pharmacological post-operative intervention in terms of the application of transcutaneous electrical nerve stimulation (TENS), could have the potential to accelerate early mobilization and reduce the use of opioids. The overall aim is to demonstrate that the addition of TENS to standard postoperative pain management of orthopedic patients can alleviate pain during mobilization and at rest

NCT ID: NCT05673941 Active, not recruiting - Clinical trials for Schizophrenia and Related Disorders

"InMotion" - Physical Training With Creative Movement as an Intervention for Adults With Schizophrenia

InMotion
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

InMotion is a randomized controlled study where adults with schizophrenia and schizophrenia-similar conditions, will be recruited to receive physical training with creative movements as an intervention, twice a week for a period of 12 weeks. The main outcome is changes in schizophrenia-related symptoms, secondary outcomes are changes in quality of life, physical and cognitive function, brain activity, and how the intervention is experienced by the participants.

NCT ID: NCT05673382 Active, not recruiting - Depressive Symptoms Clinical Trials

CrisisCope: ICBT for Psychological Symptoms Related to Life Crises.

Start date: January 19, 2023
Phase: N/A
Study type: Interventional

The aim with this study is to investigate the effects of internet-based cognitive behavioral therapy (ICBT) on psychological symptoms related to one or more life crises. The target group is adults (18 years or older) who have symptoms of depression, anxiety, stress, or other psychological distress related to one or more life crises. The ICBT consists of eight modules during eight weeks with weekly support by a therapist and the treatment group will be compared to a wait-list control condition. Participants will be recruited in Sweden with nationwide recruitment.

NCT ID: NCT05665595 Active, not recruiting - Melanoma Clinical Trials

A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)

Start date: January 19, 2023
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to compare pembrolizumab/vibostolimab to pembrolizumab with respect to recurrence-free survival (RFS). The primary hypothesis is that pembrolizumab/vibostolimab is superior to pembrolizumab with respect to RFS as assessed by the investigator in participants with high-risk resected Stage IIB, IIC, III and IV melanoma.